PETS
Price
$0.95Alerts
Change
-$0.12 (-11.21%)
Updated
Nov 12, 12:57 PM (EDT)
Capitalization
26.45M
90 days until earnings call
Intraday BUY SELL Signals
RDGT
Price
$1.16Alerts
Change
+$0.05 (+4.50%)
Updated
Nov 11 closing price
Capitalization
3.63M
Intraday BUY SELL Signals
Interact to see
Advertisement

PETS vs RDGT

PETS vs RDGT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PETS vs. RDGT commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PETS is a StrongBuy and RDGT is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PETS with price predictions
Nov 11, 2026

PETS's RSI Indicator dives oversold zone

The RSI Indicator for PETS moved into overbought territory on November 11, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PETS just turned positive on October 20, 2026. Looking at past instances where PETS's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.

Following a +1.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where PETS advanced for three days, in 144 of 226 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

PETS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 45 cases where PETS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PETS as a result. In 94 of 106 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PETS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for PETS entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.151) is normal, around the industry mean (1.378). P/E Ratio (-0.891) is within average values for comparable stocks, (-2.174). Projected Growth (PEG Ratio) (1.270) is also within normal values, averaging (0.947). PETS has a moderately high Dividend Yield (0.984) as compared to the industry average of (0.246). P/S Ratio (0.200) is also within normal values, averaging (2.504).

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. PETS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PETS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

A.I.Advisor
a Summary for RDGT with price predictions
Nov 11, 2026

Momentum Indicator for RDGT turns positive, indicating new upward trend

RDGT saw its Momentum Indicator move above the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned positive. In 82 of the 96 cases, the stock moved higher in the following days. The odds of a move higher are at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RDGT just turned positive on November 06, 2026. Looking at past instances where RDGT's MACD turned positive, the stock continued to rise in 29 of 37 cases over the following month. The odds of a continued upward trend are 78%.

RDGT moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RDGT crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

Following a +52.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDGT advanced for three days, in 168 of 206 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDGT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

RDGT broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 21 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RDGT's P/B Ratio (0.122) is slightly lower than the industry average of (1.378). P/E Ratio (0.003) is within average values for comparable stocks, (-2.174). Projected Growth (PEG Ratio) (1.090) is also within normal values, averaging (0.947). Dividend Yield (0.000) settles around the average of (0.246) among similar stocks. P/S Ratio (0.001) is also within normal values, averaging (2.504).

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. RDGT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RDGT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

FUNDAMENTALS RATINGS
PETS vs RDGT: Fundamental Ratings
PETS
RDGT
OUTLOOK RATING
1..100
596
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9821
PRICE GROWTH RATING
1..100
8061
P/E GROWTH RATING
1..100
1284
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PETS's Valuation (4) in the Drugstore Chains industry is somewhat better than the same rating for RDGT (60). This means that PETS’s stock grew somewhat faster than RDGT’s over the last 12 months.

PETS's Profit vs Risk Rating (100) in the Drugstore Chains industry is in the same range as RDGT (100). This means that PETS’s stock grew similarly to RDGT’s over the last 12 months.

RDGT's SMR Rating (21) in the Drugstore Chains industry is significantly better than the same rating for PETS (98). This means that RDGT’s stock grew significantly faster than PETS’s over the last 12 months.

RDGT's Price Growth Rating (61) in the Drugstore Chains industry is in the same range as PETS (80). This means that RDGT’s stock grew similarly to PETS’s over the last 12 months.

PETS's P/E Growth Rating (12) in the Drugstore Chains industry is significantly better than the same rating for RDGT (84). This means that PETS’s stock grew significantly faster than RDGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PETSRDGT
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
64%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (PETS: $1.07 vs. RDGT: $1.16)
Brand notoriety: PETS and RDGT are both not notable
Both companies represent the Drugstore Chains industry
Current volume relative to the 65-day Moving Average: PETS: 421% vs. RDGT: 19%
Market capitalization -- PETS: $26.45M vs. RDGT: $3.63M
PETS [@Drugstore Chains] is valued at $26.45M. RDGT’s [@Drugstore Chains] market capitalization is $3.63M. The market cap for tickers in the [@Drugstore Chains] industry ranges from $36.55K to $14.27B. The average market capitalization across the [@Drugstore Chains] industry is $82.05M.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PETS’s FA Score shows that 2 FA rating(s) are green while RDGT’s FA Score has 1 green FA rating(s).

  • PETS’s FA Score: 2 green, 3 red.
  • RDGT’s FA Score: 1 green, 4 red.
According to our system of comparison, PETS is a better buy in the long-term than RDGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PETS’s TA Score shows that 4 TA indicator(s) are bullish while RDGT’s TA Score has 5 bullish TA indicator(s).

  • PETS’s TA Score: 4 bullish, 4 bearish.
  • RDGT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RDGT is a better buy in the short-term than PETS.

Price Growth

PETS (@Drugstore Chains) experienced а -14.11% price change this week, while RDGT (@Drugstore Chains) price change was +48.72% for the same time period.

The average weekly price growth across all stocks in the @Drugstore Chains industry was +8.43%. For the same industry, the average monthly price growth was +26.23%, and the average quarterly price growth was -31.38%.

Reported Earning Dates

PETS is expected to report earnings on Feb 10, 2027.

Industries' Descriptions

@Drugstore Chains (+8.43% weekly)

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.